Headache News

The ACP issued new clinical guidance on preventing episodic migraines, classified as one to 14 headache days per month, in nonpregnant or nonlactating adults in outpatient settings.

In three clinical trials, treatment with atogepant relieved migraine symptoms as soon as day 1, with consistent reductions through 4 weeks compared with placebo, according to research published in Neurology.

Healio Neurology looks back at the most-viewed stories during the past year. Highlights include Biogen’s discontinuation of Aduhelm and a former NIH neuroscience director found guilty of research misconduct.

Headache is one of the most common complaints seen by health care providers. There are various types of primary headache disorders, with the most common being migraine, tension headache and cluster headache.

Younger and middle-aged adults were more often affected by neurologic symptoms of long COVID than their older counterparts, regardless of how severe their initial infection was, data in Annals of Neurology show.

Affecting more than 1 billion people worldwide, migraine is among the most common neurological diseases. During their lives, 43% of women and 18% of men develop migraine.

Pregabalin and topiramate significantly reduced the frequency and intensity of migraines in children and adolescents, especially when combined with vitamin supplements, according to a meta-analysis published in JAMA Network Open.

Migraine is a complex neurological disease that disproportionately affects women during their most productive years.

ORLANDO, Fla. — Although children often suffer from headache, there are few controlled trials that include this unique patient population, leaving clinicians to rely on their experience rather than data, according to a presenter.